Munit provides unparalleled high containment micronization services for Highly Potent Active Pharmaceutical Ingredients (HPAPIs) within the pharmaceutical industry. Our processes are meticulously executed in dedicated isolators with stringent adherence to all safety protocols, ensuring comprehensive protection for products, operators, and the environment.

Our experienced team, coupled with state-of-the-art equipment and strict adherence to current Good Manufacturing Practices (cGMP) guidelines, guarantees the highest-quality particle size dimensions crucial for your drug product. Our advanced technology enables us to precisely micronize highly potent compounds to levels as fine as 1 micron, delivering excellent particle size distribution. This critical control significantly improves uniformity, accelerates solubility, enhances bioavailability, and facilitates optimal pulmonary target size delivery where applicable.

At Munit, we offer flexible development options designed to optimise your drug formulation, spanning from small-scale laboratory feasibility studies to full-scale commercial manufacturing. Our dedicated project management team ensures transparent communication through regular updates and guarantees the timely delivery of your micronized HPAPIs.

With years of profound experience in micronization, Munit stands as a trusted partner in the pharmaceutical industry, committed to advancing the development of safe and effective HPAPI-based drug products.